Skip to main content
Premium Trial:

Request an Annual Quote

Ciphergen Buys Remaining Stake in Its Japanese Affiliate from SC BioSciences

NEW YORK, March 25 (GenomeWeb News) - Ciphergen Biosystems has bought the remaining stake in its Japanese affiliate Ciphergen Biosystems K.K. from SC BioSciences, assuming full ownership, Ciphergen said today.


Ciphergen acquired the 30 percent equity stake held by SC BioSciences, a unit of Sumitomo. Ciphergen and SC BioSciences founded the affiliate in 1999 as a joint venture. In August 2002, Ciphergen increased its stake from 30 percent from 70 percent and founded a Biomarker Discovery Center in Japan.


Complete ownership "will give us greater flexibility to expand our operations in Japan going forward, in particular as we capitalize on the opportunities created by our diagnostics division," said Ciphergen president and CEO Bill Rich in a statement.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.